HaysMac played a significant role in Vulcan Two’s successful admission to AIM; the London Stock Exchange’s growth segment.
Vulcan Two Group PLC (‘Vulcan Two’) has raised £12m of capital upon IPO in order to begin its journey of building a seamless digital healthcare experience for patients by integrating online pharmacies and private prescription providers across a historically fragmented market in the UK.
